Categories AlphaGraphs, Health Care

Pfizer (PFE) Q2 2022 Earnings: Key financials and quarterly highlights

Pfizer Inc. (NYSE: PFE) reported second quarter 2022 earnings results today.

Total revenues increased 47% year-over-year to $27.7 billion.

Reported net income rose 78% to $9.9 billion, or $1.73 per share, compared to last year. Adjusted EPS jumped 92% YoY to $2.04.

Pfizer raised its revenue and adjusted EPS guidance for the full year of 2022. The company now expects revenue of 98-102 billion and adjusted EPS of $6.30-6.45 for the year, reflecting operational growth of 27-32% and 63-67% respectively.

Prior performance

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

WMT Earnings: All you need to know about Walmart’s Q2 2023 earnings results

Walmart Inc. (NYSE: WMT) reported second quarter 2023 earnings results today. Total revenue increased 8.4% year-over-year to $152.9 billion. Revenues grew 9.1% in constant currency. Consolidated net income attributable to

Rivian (RIVN) reaffirms production goals. Will it be a smooth ride?

The evolution of the electric vehicle industry accelerated in recent years even as innovations in battery technology and affordability brought EVs into the mainstream. Encouraged by the success of market

Pfizer (PFE): A look at the headwinds and tailwinds this pharma giant faces in the near term

Shares of Pfizer Inc. (NYSE: PFE) were down on Monday. The stock has dropped 15% year-to-date and there is a mixed sentiment surrounding the company’s growth prospects. Pfizer has benefited

Add Comment
Viewing Highlight